Xtant Medical Holdings, Inc. Stock

Equities

XTNT

US98420P3082

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
0.7844 USD -0.62% Intraday chart for Xtant Medical Holdings, Inc. -11.27% -30.58%
Sales 2024 * 115M Sales 2025 * 130M Capitalization 102M
Net income 2024 * -8M Net income 2025 * - EV / Sales 2024 * 0.89 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.78 x
P/E ratio 2024 *
-13.1 x
P/E ratio 2025 *
-157 x
Employees 211
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.62%
1 week-11.27%
Current month-32.96%
1 month-32.38%
3 months-28.04%
6 months-28.69%
Current year-30.58%
More quotes
1 week
0.76
Extreme 0.76
0.95
1 month
0.76
Extreme 0.76
1.24
Current year
0.76
Extreme 0.76
1.31
1 year
0.60
Extreme 0.5988
1.45
3 years
0.43
Extreme 0.4291
2.38
5 years
0.43
Extreme 0.4291
6.58
10 years
0.43
Extreme 0.4291
102.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 19-10-06
Director of Finance/CFO 40 19-07-31
Chief Operating Officer - 23-01-15
Members of the board TitleAgeSince
Director/Board Member 58 23-05-15
Director/Board Member 63 18-01-31
Director/Board Member 67 18-01-31
More insiders
Date Price Change Volume
24-04-17 0.7844 -0.62% 183,927
24-04-16 0.7893 -8.22% 276,873
24-04-15 0.86 +2.72% 64,665
24-04-12 0.8372 -4.86% 88,394
24-04-11 0.88 -0.45% 108,380

Delayed Quote Nyse, April 17, 2024 at 04:00 pm EDT

More quotes
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7844 USD
Average target price
1.925 USD
Spread / Average Target
+145.41%
Consensus